Stem Cells Market Size, Share & Trends Report

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine, Drug Discovery & Development), By Technology, Therapy, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-130-6
  • Number of Pages: 195
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2023
  • Industry: Healthcare

Market Segmentation

  • Global Stem Cells Market: Product Outlook (Revenue, USD Million, 2022 - 2030)
    • Adult Stem Cells (ASCs)
      • Hematopoietic
      • Mesenchymal
      • Neural
      • Epithelial/Skin
      • Others
    • Human Embryonic Stem Cells (HESCs)
    • Induced Pluripotent Stem Cells (iPSCs)
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market: Application Outlook (Revenue, USD Million, 2022 - 2030)
    • Regenerative Medicine
      • Neurology
      • Orthopedics
      • Oncology
      • Hematology
      • Cardiovascular and Myocardial Infraction
      • Injuries
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others
    • Drug Discovery and Development
  • Global Stem Cells Market: Technology Outlook (Revenue, USD Million, 2022 - 2030)
    • Cell Acquisition
      • Bone Marrow Harvest
      • Umbilical Blood Cord
      • Apheresis
    • Cell Production
      • Therapeutic Cloning
      • In-vitro Fertilization
      • Cell Culture
      • Isolation
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market: Therapy Outlook (Revenue, USD Million, 2022 - 2030)
    • Autologous
    • Allogenic
  • Global Stem Cells Market: Therapy Outlook (Revenue, USD Million, 2022 - 2030)
    • Pharmaceutical and Biotechnology Companies
    • Hospitals & Cell Banks
    • Academic & Research Institutes
  • Stem Cells: Regional Outlook (Revenue, USD Million, 2022 - 2030)
    • North America
      • North America Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • North America Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • North America Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • North America Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • North America Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • U.S.
        • U.S. Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • U.S. Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • U.S. Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • U.S. Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • U.S. Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Canada
        • Canada Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Canada Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Canada Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Canada Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Canada Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Europe
      • Europe Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Europe Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Europe Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Europe Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Europe Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Others
      • Germany
        • Germany Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Germany Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Germany Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Germany Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Germany Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • U.K.
        • U.K. Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • U.K. Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • U.K. Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • U.K. Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • U.K. Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • France
        • France Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • France Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • France Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • France Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • France Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Spain
        • Spain Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Spain Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Spain Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Spain Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Spain Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Italy
        • Italy Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Italy Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Italy Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Italy Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Italy Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Denmark
        • Denmark Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Denmark Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Denmark Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Denmark Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Denmark Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Sweden
        • Sweden Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Sweden Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Sweden Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Sweden Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Sweden Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Norway
        • Norway Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Norway Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Norway Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Norway Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Norway Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Asia Pacific
      • Asia Pacific Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Asia Pacific Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Asia Pacific Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Asia Pacific Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Asia Pacific Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • China
        • China Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • China Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • China Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • China Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • China Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Japan
        • Japan Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Japan Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Japan Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Japan Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Japan Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Others
      • India
        • India Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • India Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • India Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • India Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • India Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • South Korea
        • South Korea Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • South Korea Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • South Korea Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • South Korea Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • South Korea Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Australia
        • Australia Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Australia Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Australia Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Australia Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Australia Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Thailand
        • Thailand Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Thailand Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Thailand Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Thailand Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Thailand Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Latin America
      • Latin America Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Latin America Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Latin America Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Latin America Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Latin America Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • Brazil
        • Brazil Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Brazil Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Brazil Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Brazil Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Brazil Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Mexico
        • Mexico Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Mexico Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Mexico Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Mexico Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Mexico Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Argentina
        • Argentina Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Argentina Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Argentina Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Argentina Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Argentina Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
    • Middle East & Africa
      • Middle East & Africa Stem Cells Market, by Product 2022 - 2030 (USD Million)
        • Adult Stem Cells (ASCs)
          • Hematopoietic
          • Mesenchymal
          • Neural
          • Epithelial/Skin
          • Others
        • Human Embryonic Stem Cells (HESCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Very Small Embryonic Like Stem Cells
      • Middle East & Africa Stem Cells Market, by Application 2022 - 2030 (USD Million)
        • Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Hematology
          • Cardiovascular and Myocardial Infraction
          • Injuries
          • Diabetes
          • Liver Disorder
          • Incontinence
          • Others
        • Drug Discovery and Development
      • Middle East & Africa Stem Cells Market, by Technology 2022 - 2030 (USD Million)
        • Cell Acquisition
          • Bone Marrow Harvest
          • Umbilical Blood Cord
          • Apheresis
        • Cell Production
          • Therapeutic Cloning
          • In-vitro Fertilization
          • Cell Culture
          • Isolation
        • Cryopreservation
        • Expansion and Sub-Culture
      • Middle East & Africa Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
        • Autologous
        • Allogenic
      • Middle East & Africa Stem Cells Market, by End User 2022 - 2030 (USD Million)
        • Pharmaceutical and Biotechnology Companies
        • Hospitals & Cell Banks
        • Academic & Research Institutes
      • South Africa
        • South Africa Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • South Africa Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • South Africa Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • South Africa Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • South Africa Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Saudi Arabia
        • Saudi Arabia Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Saudi Arabia Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Saudi Arabia Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Saudi Arabia Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Saudi Arabia Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • UAE
        • UAE Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • UAE Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • UAE Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • UAE Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • UAE Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes
      • Kuwait
        • Kuwait Stem Cells Market, by Product 2022 - 2030 (USD Million)
          • Adult Stem Cells (ASCs)
            • Hematopoietic
            • Mesenchymal
            • Neural
            • Epithelial/Skin
            • Others
          • Human Embryonic Stem Cells (HESCs)
          • Induced Pluripotent Stem Cells (iPSCs)
          • Very Small Embryonic Like Stem Cells
        • Kuwait Stem Cells Market, by Application 2022 - 2030 (USD Million)
          • Regenerative Medicine
            • Neurology
            • Orthopedics
            • Oncology
            • Hematology
            • Cardiovascular and Myocardial Infraction
            • Injuries
            • Diabetes
            • Liver Disorder
            • Incontinence
            • Others
          • Drug Discovery and Development
        • Kuwait Stem Cells Market, by Technology 2022 - 2030 (USD Million)
          • Cell Acquisition
            • Bone Marrow Harvest
            • Umbilical Blood Cord
            • Apheresis
          • Cell Production
            • Therapeutic Cloning
            • In-vitro Fertilization
            • Cell Culture
            • Isolation
          • Cryopreservation
          • Expansion and Sub-Culture
        • Kuwait Stem Cells Market, by Therapy 2022 - 2030 (USD Million)
          • Autologous
          • Allogenic
        • Kuwait Stem Cells Market, by End User 2022 - 2030 (USD Million)
          • Pharmaceutical and Biotechnology Companies
          • Hospitals & Cell Banks
          • Academic & Research Institutes

Stem Cells Market Dynamics

Drivers: Ongoing Developments In Regenerative Medicine

Growing demand for regenerative medicines is expected to propel the market for stem cells. Regenerative medicines have extensive applications in the treatment of various medical conditions such as Parkinson's, Crohn's diseases, cardiovascular tissue repair, skin wounds, and organ transplants. It is widely used in fields such as neurology, oncology, hepatology, diabetes, injuries, hematology, and orthopedics. In addition, the growing geriatric population and increasing demand for regenerative medicines for the early detection & prevention of diseases are some of the factors contributing to market growth. Regenerative medicines help in restoring the normal functioning of cells. The introduction of novel tools and solutions that are accurate and can be used conveniently has led to the development of pioneering technologies leading to advancements in the field of regenerative medicine. The field of regenerative medicine is witnessing continuous developments, and products have found use in several therapeutic applications.

Rising Funds For Accelerating Stem Cell Research

The stem cell industry is expected to grow significantly over the forecast period due to an increase in healthcare expenditure in developed countries and improvisation in healthcare facilities in developing countries. Government initiatives such as the Patient Protection and Affordable Care Act (ACA) and increased access to healthcare facilities are some of the factors responsible for the growth of this market in developed countries. Robust funding to biotechnology companies is expected to boost the stem cell market owing to the use of different biotechnological kits and products in cell development, collection, characterization, and storage processes in stem cell banking. Furthermore, the market is also expected to grow as a consequence of extensive applications in different fields such as gene therapy, drug discovery, and personalized medicine. In addition, over the recent years, various organizations have come forward to fund stem cell centers and entities, further encouraging research activities performed to unlock the potential of stem cells in therapeutics.

Restraints: Ethical Concerns Related To Stem Cell Research

Research on human embryonic stem cells creates a moral dilemma. It involves choosing between human life and the prevention of suffering. Harvesting of embryonic stem cells involves the destruction of the human embryo, which raises a moral concern. In addition, stringent regulations for obtaining Intellectual Property Rights for products or materials used in research are major restraints for the commercialization of such services. Ethical approval should be obtained for the storage of cell lines and tissues in biorepositories to avoid the usage of tissue for an illegal purpose or for proxy identification of diseases to claim insurance. Moreover, controversies surrounding the use of embryonic stem cells for research and prognosis are restraining the market growth in several regions.

What Does This Report Include?

This section will provide insights into the contents included in this stem cells market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Stem cells market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Stem cells market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon